Figure 11

![Figure 11: In vitro or in silico evaluation results for novel NSAID-derived molecules targeting neurodegenerative pathways. The data assess binding affinity, selectivity, or cellular neuroprotection relevant to Alzheimer's disease.]()

> Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." *International journal of molecular sciences*, 2016. PMID: [27376271](https://pubmed.ncbi.nlm.nih.gov/27376271/)

<figure>
  <img src="" alt="In vitro or in silico evaluation results for novel NSAID-derived molecules targeting neurodegenerative pathways. The data assess binding affinity, selectivity, or cellular neuroprotection relevant to Alzheimer's disease." />
  <figcaption>Figure 11. In vitro or in silico evaluation results for novel NSAID-derived molecules targeting neurodegenerative pathways. The data assess binding affinity, selectivity, or cellular neuroprotection relevant to Alzheimer's disease.<br>  Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." <em>International journal of molecular sciences</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27376271/">27376271</a></figcaption>
</figure>